Paraoxonase polymorphisms, haplotypes, and enyzme activity in Latino mothers and newborns

Environmental Health Perspectives

Volumn 114, Issue 7, 2006, Pages 985-991

  Holland, Nina ^a   Furlong, Clement ^b   Bastaki, Maria ^a   Richter, Rebecca ^b   Bradman, Asa ^a   Huen, Karen ^a   Beckman, Kenneth ^c   Eskenazi, Brenda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Chlorpyrifos; Cord blood; Genotype; Haplotypes; Latino cohort; Linkage disequilibrium; Organophosphate; Paraoxonase 1 (PON1); Paraoxonase activity; Pesticides; PON1 polymorphisms; Pregnancy

Indexed keywords

ADENINE; ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; CHLORPYRIFOS; CYTOSINE; GUANINE; ORGANOPHOSPHATE PESTICIDE; PHENYLACETIC ACID; TYROSINE;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DETOXIFICATION; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; HUMAN CELL; LINKAGE ANALYSIS; MALE; NEWBORN; PREDICTION; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROMOTER REGION; TOXICOKINETICS; UNITED STATES;

ADOLESCENT; ADULT; ARYLDIALKYLPHOSPHATASE; FEMALE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; LATIN AMERICA; MOTHERS; PHENOTYPE; POLYMORPHISM, GENETIC; PREGNANCY;

EID: 33745779870     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.8540     Document Type: Article

References (61)

1. Allebrandt KV, Souza RL, Chautard-Freire-Maia EA. 2002. Variability of the paraoxonase gene (PON1) in Euro- and Afro-Brazilians. Toxicol Appl Pharmacol 180:151-156.
2. Augustinsson K, Barr M. 1963. Age variation in plasma arylesterase activity in children. Clin Chim Acta 8:568-573.
3. Barr D, Bravo R, Weerasekera G, Caltabiano L, Whitehead R. 2004. Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 112:186-200.
4. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
5. Berkowitz GS, Obel J, Deych E, Lapinski R, Godbold J, Liu Z, et al. 2003. Exposure to indoor pesticides during pregnancy in a multiethnic, urban cohort. Environ Health Perspect 111:79-84.
6. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, Godbold JH, et al. 2004. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect 112:388-391.
7. Blatter-Garin M-C, Abbot C, Messmer S, Mackness MI, Durrington P, Pometta D, et al. 1994. Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J 304:549-554.
8. Bradman A, Barr DB, Claus Henn BG, Drumheller T, Curry C, Eskenazi B. 2003. Measurement of pesticides and other toxicants in amniotic fluid as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 111:1782-1789.
9. Bradman A, Eskenazi B, Barr DB, Bravo R, Castorina R, Chevrier J, et al. 2005. Organophosphate urinary metabolite levels during pregnancy and after delivery in women living in an agricultural community. Environ Health Perspect 113:1802-1807.
10. Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. 2001a. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11:77-84.
11. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. 2001b. Effects of 5′ regulatory region polymorphisms on paraoxonase (PON1) expression. Am J Hum Genet 68:1428-1436.
12. Brophy VH, Jarvik GP, Furlong C. 2002. PON1 polymorphisms. In: Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects (Costa LG, Furlong C, eds). Boston, MA: Kluwer Academic Press, 53-77.
13. California Environmental Protection Agency. 2002. Pesticide Use Reporting 2001 Summary Data. Sacramento: California Environmental Protection Agency, Department of Pesticide Regulation. Available: http://www.cdpr.ca.gov/docs/pur/pur01rep/01_pur.htm [accessed 1 December 2005].
14. Castorina R, Bradman A, McKone TE, Marr D, Harnly M, Eskenazi B. 2003. Cumulative organophosphate pesticide exposure and risk assessment among pregnant women living in an agricultural community: a case study from the CHAMACOS cohort. Environ Health Perspect 111:1642-1648.
15. Cavalli-Sforza L, Menozzi P, Piazza A. 1994. History and Geography of Human Genes. Princeton, NJ: Princeton University Press.
16. Chen D, Hu Y, Chen C, Yang F, Fang Z, Wang L, et al. 2004. Polymorphisms of the paraoxonase gene and risk of preterm delivery. Epidemiology 15:466-470.
17. Chen J, Chan W, Wallenstein S, Berkowitz G, Wetmur JG. 2005. Haplotype-phenotype relationships of paraoxonase-1. Cancer Epidemiol Biomarkers Prev 14:731-734.
18. Chen J, Kumar M, Chan W, Berkowitz G, Wetmur JG. 2003. Increased influence of genetic variation on PON1 activity in neonates. Environ Health Perspect 111:1403-1409.
19. Cole T, Jampsa RL, Walter BJ, Arndt TL, Richter RJ, Shih DM, et al. 2003. Expression of human paraoxonase (PON1) during development. Pharmacogenetics 13:357-364.
20. Cole T, Walter B, Shih D, Tward A, Lusis AJ, Timchalk C, et al. 2005. Toxicity of chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genom 15:589-598.
21. Costa LG, Li WF, Richter RJ, Shih DM, Lusis AJ, Furlong CE. 2002. PON1 and organophosphate toxicity. In: Paraoxonase (PON1) in Health and Disease: Basic and Clinical Aspects (Costa LG, Furlong CE, eds). Boston, MA: Kluwer Academic Press, 165-184.
22. Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE. 1996. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334-336.
23. Deakin S, Leviev I, Brulhart-Meynet M-C, James RW. 2003. Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position -107, implicating the Sp1 transcription factor. Biochem J 372:643-649.
24. Draganov DI, Teiber JF, Speelman A, Osawa Y, Sunahara R, La Du BN. 2005. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J Lipid Res 46:1239-1247.
25. Ecobichon DJ, Stephens DS. 1973. Perinatal development of human blood esterases. Clin Pharmacol Ther 14:41-47.
26. Eskenazi B, Bradman A, Castorina R. 1999. Exposures of children to organophosphate pesticides and their potential adverse health effects. Environ Health Perspect 107(suppl 3):409-419.
27. Eskenazi B, Bradman A, Gladstone EA, Jaramillo S, Birch K, Holland NT. 2003. CHAMACOS, a longitudinal birth cohort study: lessons from the fields. J Childrens Health 1:3-27.
28. Eskenazi B, Harley K, Bradman A, Weltzien E, Jewell NP, Barr DB, et al. 2004. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect 112:1116-1124.
29. Fenske RA, Lu C, Barr D, Needham L. 2002. Children's exposure to chlorpyrifos and parathion in an agricultural community in central Washington State. Environ Health Perspect 110:549-553.
30. Furlong C, Holland N, Richter R, Bradman A, Ho A, Eskenazi B. 2006. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genom 16:183-190.
31. Furlong C, Li W-F, Shih DM, Lusis AJ, Richter RJ, Costa L. 2002. Genetic factors in susceptibility: serum PON1 variation between individuals and species. Hum Ecol Risk Assess 8:31-43.
32. Furlong CE, Costa LG, Hassett C, Richter RJ, Adler DA, Disteche CM, et al. 1993. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol Interact 87:35-48.
33. Geldmacher-von Mallinckrodt M, Diepgen TL. 1988. The human serum paraoxonase - polymorphism and specificity. Toxicol Environ Chem 18:179-196.
34. Hill RH Jr, Head SL, Baker S, Gregg M, Shealy DB, Bailey SL, et al. 1995. Pesticide residues in urine of adults living in the United States: reference range concentrations. Environ Res 71:99-108.
35. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. 1993. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73-76.
36. International HapMap Consortium. 2003. The International HapMap Project. Nature 426:789-796.
37. James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC. 2000. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients. Diabetes 49:1390-1393.
38. Jarvik GP, Jampsa R, Richter RJ, Carlson CS, Rieder MJ, Nickerson DA, et al. 2003. Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status. Pharmacogenetics 13:291-295.
39. Koda Y, Tachida H, Soejima M, Takenaka O, Kimura H. 2004. Population differences in DNA sequence variation and linkage disequilibrium at the PON1 gene. Ann Hum Genet 68:110-119.
40. Lancaster A, Nelson MP, Single RM, Meyer D, Thomson G. 2003. PyPop: a software framework for population genomics: analyzing large-scale multi-locus genotype data. In: Pacific Symposium on Biocomputing 8 (Altman RB, Dunker AK, Hunter L, Jung TA, Klein TE, eds). Singapore: World Scientific, 514-525.
41. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, et al. 2000. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10:767-779.
42. Loewenherz C, Fenske RA, Simcox NJ, Bellamy G, Kalman D. 1997. Biological monitoring of organophosphorus pesticide exposure among children of agricultural workers in central Washington State. Environ Health Perspect 105:1344-1353.
43. Mueller RF, Hornung S, Furlong CE, Anderson J, Giblett ER, Motulsky AG. 1983. Plasma paraoxonase polymorphism: a new enzyme assay, population, family, biochemical, and linkage studies. Am J Hum Genet 35:393-408.
44. National Research Council. 1993. Pesticides in the Diets of Infants and Children. Washington, DC: National Academy of Sciences.
45. Padilla S, Buzzard J, Moser VC. 2000. Comparison of the role of esterases in the differential age-related sensitivity to chlorpyrifos and methamidophos. Neurotoxicology 21:49-56.
46. Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN. 1996. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498-507.
47. Richter R, Jampsa R, Jarvik GP, Costa LG, Furlong C. 2004. Determination of paraoxonase 1 (PON1) status and genotypes at specific polymorphic sites. Curr Protocols Toxicol 4:12-19.
48. Richter RJ, Furlong CE. 1999. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9:745-753.
49. Rojas-Garcia AE, Solis-Heredia MJ, Pina-Guzman B, Vega L, Lopez-Carrillo L, Quintanilla-Vega B. 2005. Genetic polymorphisms and activity of PON1 in a Mexican population. Toxicol Appl Pharmacol 205(3):282-289.
50. SeattleSNPs. 2005. NHLBI Program for Genomic Applications. Seattle, WA: SeattleSNPs. Available: http://pga.gs.washington.edu [accessed 1 July 2005].
51. Sheets L. 2000. A consideration of age-dependent differences in susceptibility to organophosphorus and pyrethroid insecticides. Neurotoxicology 21:57-63.
52. Simcox NJ, Camp J, Kalman D, Stebbins A, Bellamy G, Lee IC, et al. 1999. Farmworker exposure to organophosphorus pesticide residues during apple thinning in central Washington state. Am Ind Hyg Assoc J 60:752-761.
53. Stephens M, Donnelly P. 2003. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162-1169.
54. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978-989.
55. Stram DO, Haiman CA, Hirschhorn JN, Altshuler D, Kolonel LN, Henderson BE, Pike MC. 2003. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum Hered 55:27-36.
56. Suehiro T, Nakamura T, Inoue M, Shiinoki T, Ikeda Y, Kumon Y, et al. 2000. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis 150:295-298.
57. Watson AD, Berliner JA, Hama SY, La Du BN, Faull KF, Fogelman AM, et al. 1995. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest 96:2882-2891.
58. Wetmur JG, Kumar M, Zhang L, Palomeque C, Wallenstein S, Chen J. 2005. Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes. Nucleic Acids Res 33:2615-2619.
59. Whyatt RM, Barr DB. 2001. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 103:417-420.
60. Whyatt RM, Barr DB, Camann DE, Kinney PL, Barr JR, Andrews HF, et al. 2003. Contemporary-use pesticides in personal air samples during pregnancy and blood samples at delivery among urban minority mothers and newborns. Environ Health Perspect 111:749-756.
61. Young JG, Eskenazi B, Gladstone EA, Bradman A, Pedersen L, Johnson C, et al. 2005. Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates. Neurotoxicology 26:199-209.